Tivity Health Inc. filed SEC Form 8-K: Leadership Update

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported):  July 8, 2022 (July 2, 2022)

 

TIVITY HEALTH, INC.

 

(Exact name of registrant as specified in its charter)

 

 

 

(800) 869-5311

(Registrant's telephone number, including area code)

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

 

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

None.

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 

---

 

 

 

 

On July 2, 2022, Tivity Health, Inc. (the “Company”) entered into a Separation and Consulting Agreement and General Release (the “Separation Agreement”) with Adam Holland, Chief Financial Officer of the Company, which provided for the termination of Mr. Holland’s employment with the Company.  The Separation Agreement also provides that Mr. Holland will receive those separation payments and benefits that he is entitled to receive under his employment agreement in respect of a termination without cause, which agreement has previously been disclosed. Mr. Holland will provide consulting services to the Company for a period of 30 days in order to facilitate the transition to his successor and will receive a consulting fee of $36,500 for providing such consulting services.

 

 

---

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: July 8, 2022